Tags

Type your tag names separated by a space and hit enter

Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions.
Front Surg. 2019; 6:50.FS

Abstract

Introduction: Intra-uterine adhesion (IUA) is one of the main causes of secondary infertility. The aim of this study was to evaluate the prevalence of IUA developing in women undergoing hysteroscopic resection for submucous myomas, polyps, and intrauterine synechiae and test the efficacy of second look hysteroscopy for diagnosing and treating post-surgical adhesions. Materials and

Methods:

We retrospectively collected data from reproductive age women who had a second look office hysteroscopy following hysteroscopic resection for myoma, polyp, or IUA at Foch hospital (Suresnes, France) between 2009 and 2017.

Results:

Six hundred and twenty two reproductive-age women underwent hysteroscopic resection for myoma, polyp, and/or IUA. Among them, 155 women had a second look hysteroscopy. In this group, 29/155 (18.7%) had IUA formation: 17/83 (20.5%) women who underwent hysteroscopic myomectomy, 5/46 (10.9%) women who underwent hysteroscopic polypectomy, and 7/26 (26.9%) women who underwent hysteroscopic lysis of adhesions. These IUA have been lysed by the office hysteroscopy procedure in 16/29 (55.2%) patients: 11/17 (64.7%), 2/5 (40%), and 3/7 (42.9%) in women who underwent hysteroscopic myomectomy, polypectomy and lysis of adhesion, respectively.

Conclusion:

IUA is a common complication of hysteroscopic surgery. Second look office hysteroscopy is an easy and effective procedure for diagnosing and removing newly formed IUA. It should be recommended for all women undergoing hysteroscopic resection for myomas, polyps, or IUA.

Authors+Show Affiliations

Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31475154

Citation

Sebbag, Lauren, et al. "Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions." Frontiers in Surgery, vol. 6, 2019, p. 50.
Sebbag L, Even M, Fay S, et al. Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions. Front Surg. 2019;6:50.
Sebbag, L., Even, M., Fay, S., Naoura, I., Revaux, A., Carbonnel, M., Pirtea, P., de Ziegler, D., & Ayoubi, J. M. (2019). Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions. Frontiers in Surgery, 6, 50. https://doi.org/10.3389/fsurg.2019.00050
Sebbag L, et al. Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions. Front Surg. 2019;6:50. PubMed PMID: 31475154.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions. AU - Sebbag,Lauren, AU - Even,Marc, AU - Fay,Stéphanie, AU - Naoura,Iptissem, AU - Revaux,Aurélie, AU - Carbonnel,Marie, AU - Pirtea,Paul, AU - de Ziegler,Dominique, AU - Ayoubi,Jean-Marc, Y1 - 2019/08/16/ PY - 2019/05/13/received PY - 2019/07/30/accepted PY - 2019/9/3/entrez PY - 2019/9/3/pubmed PY - 2019/9/3/medline KW - adhesion prevention KW - hysteroscopic resection KW - intra uterine synechiae KW - intra-uterine adhesions KW - office hysteroscopy KW - second look hysteroscopy SP - 50 EP - 50 JF - Frontiers in surgery JO - Front Surg VL - 6 N2 - Introduction: Intra-uterine adhesion (IUA) is one of the main causes of secondary infertility. The aim of this study was to evaluate the prevalence of IUA developing in women undergoing hysteroscopic resection for submucous myomas, polyps, and intrauterine synechiae and test the efficacy of second look hysteroscopy for diagnosing and treating post-surgical adhesions. Materials and Methods: We retrospectively collected data from reproductive age women who had a second look office hysteroscopy following hysteroscopic resection for myoma, polyp, or IUA at Foch hospital (Suresnes, France) between 2009 and 2017. Results: Six hundred and twenty two reproductive-age women underwent hysteroscopic resection for myoma, polyp, and/or IUA. Among them, 155 women had a second look hysteroscopy. In this group, 29/155 (18.7%) had IUA formation: 17/83 (20.5%) women who underwent hysteroscopic myomectomy, 5/46 (10.9%) women who underwent hysteroscopic polypectomy, and 7/26 (26.9%) women who underwent hysteroscopic lysis of adhesions. These IUA have been lysed by the office hysteroscopy procedure in 16/29 (55.2%) patients: 11/17 (64.7%), 2/5 (40%), and 3/7 (42.9%) in women who underwent hysteroscopic myomectomy, polypectomy and lysis of adhesion, respectively. Conclusion: IUA is a common complication of hysteroscopic surgery. Second look office hysteroscopy is an easy and effective procedure for diagnosing and removing newly formed IUA. It should be recommended for all women undergoing hysteroscopic resection for myomas, polyps, or IUA. SN - 2296-875X UR - https://www.unboundmedicine.com/medline/citation/31475154/Early_Second_Look_Hysteroscopy:_Prevention_and_Treatment_of_Intrauterine_Post_surgical_Adhesions_ L2 - https://doi.org/10.3389/fsurg.2019.00050 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.